In Brief This Week: Qiagen, FDA, Yourgene, and More

The Scan

CMS Letter to Orig3n

Bloomberg reports the US Centers for Medicare & Medicaid Services sent Orig3n a letter saying it has not corrected lab issues uncovered in an earlier inspection.

And After the Test

In an editorial at the BMJ Opinion, two genetic counselors call for an increased focus on post-test patient care.

Faster, But Not Fast Enough

A new survey finds people in the US are getting their COVID-19 test results back faster, but not fast enough to help some viral control measures, NPR reports.

PLOS Papers on Plasmodium vivax Variation in Ethiopia, Childhood BMI Loci, More

In PLOS this week: genomic analysis of malaria parasites in Ethiopia, loci linked to childhood BMI, and more.

Menu

In Brief This Week: Qiagen, FDA, Yourgene, and More

To read the full story....

Breaking News

CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon

Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing

FDA Reissues Emergency Use Authorization for Thermo Fisher Scientific COVID-19 Combo Kit

LumiraDx Gets FDA Emergency Use Authorization for PCR-Based Coronavirus Test

Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs

In Brief This Week: PerkinElmer, Rady Children's Institute for Genomic Medicine, Myriad Genetics, and More

The Scan

CMS Letter to Orig3n

And After the Test

Faster, But Not Fast Enough

PLOS Papers on Plasmodium vivax Variation in Ethiopia, Childhood BMI Loci, More

Sponsorships